These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects. Kar S Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796 [TBL] [Abstract][Full Text] [Related]
6. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature. Ito MK Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750 [TBL] [Abstract][Full Text] [Related]
7. Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis. Quispe R; Alfaddagh A; Kazzi B; Zghyer F; Marvel FA; Blumenthal RS; Sharma G; Martin SS Curr Atheroscler Rep; 2022 Jul; 24(7):571-581. PubMed ID: 35499805 [TBL] [Abstract][Full Text] [Related]
8. Omega-3 polyunsaturated fatty acids: anti-inflammatory and anti-hypertriglyceridemia mechanisms in cardiovascular disease. Shibabaw T Mol Cell Biochem; 2021 Feb; 476(2):993-1003. PubMed ID: 33179122 [TBL] [Abstract][Full Text] [Related]
9. [Treatment of hypertriglyceridemia with omega-3 fatty acids]. Miyoshi T; Ito H Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729 [TBL] [Abstract][Full Text] [Related]
10. Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial. Kastelein JJ; Maki KC; Susekov A; Ezhov M; Nordestgaard BG; Machielse BN; Kling D; Davidson MH J Clin Lipidol; 2014; 8(1):94-106. PubMed ID: 24528690 [TBL] [Abstract][Full Text] [Related]
11. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention. Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253 [TBL] [Abstract][Full Text] [Related]
12. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3. Pirillo A; Catapano AL Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523 [TBL] [Abstract][Full Text] [Related]
13. Prescription omega-3 fatty acids and their lipid effects: physiologic mechanisms of action and clinical implications. Bays HE; Tighe AP; Sadovsky R; Davidson MH Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):391-409. PubMed ID: 18327998 [TBL] [Abstract][Full Text] [Related]
14. History and future of omega-3 fatty acids in cardiovascular disease. Sperling LS; Nelson JR Curr Med Res Opin; 2016; 32(2):301-11. PubMed ID: 26566071 [TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acids: their role in the prevention and treatment of atherosclerosis related risk factors and complications. Bhatnagar D; Durrington PN Int J Clin Pract; 2003 May; 57(4):305-14. PubMed ID: 12800463 [TBL] [Abstract][Full Text] [Related]
16. The effect of omega-3 carboxylic acids on apolipoprotein CIII-containing lipoproteins in severe hypertriglyceridemia. Morton AM; Furtado JD; Lee J; Amerine W; Davidson MH; Sacks FM J Clin Lipidol; 2016; 10(6):1442-1451.e4. PubMed ID: 27919362 [TBL] [Abstract][Full Text] [Related]
17. Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. Nicholls SJ; Lincoff AM; Garcia M; Bash D; Ballantyne CM; Barter PJ; Davidson MH; Kastelein JJP; Koenig W; McGuire DK; Mozaffarian D; Ridker PM; Ray KK; Katona BG; Himmelmann A; Loss LE; Rensfeldt M; Lundström T; Agrawal R; Menon V; Wolski K; Nissen SE JAMA; 2020 Dec; 324(22):2268-2280. PubMed ID: 33190147 [TBL] [Abstract][Full Text] [Related]
18. N-3 polyunsaturated fatty acids in the treatment of atherogenic dyslipidemia. Vecka M; Dušejovská M; Stankova B; Zeman M; Vavrova L; Kodydkova J; Slaby A; Zak A Neuro Endocrinol Lett; 2012; 33 Suppl 2():87-92. PubMed ID: 23183517 [TBL] [Abstract][Full Text] [Related]
19. The effect of a 12-week course of omega-3 polyunsaturated fatty acids on lipid parameters in hypertriglyceridemic adult HIV-infected patients undergoing HAART: a randomized, placebo-controlled pilot trial. Peters BS; Wierzbicki AS; Moyle G; Nair D; Brockmeyer N Clin Ther; 2012 Jan; 34(1):67-76. PubMed ID: 22212377 [TBL] [Abstract][Full Text] [Related]
20. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved. Watanabe Y; Tatsuno I J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]